Efectos adversos relacionados al uso de AINEs en el manejo de osteoartritis felina y canina

Autores:: González-Corrales, Daniela
Monge-Quirós, Tatiana
Alfaro-Mora, Ramses

Tipo de recurso:: Article of journal

Fecha de publicación:: 2020

Institución:: Universidad de Sucre

Repositorio:: Repositorio Unisucre

Idioma:: spa

id	RUNISUCRE2_70cd84f58a480299eac463cf97ce9b74
oai_identifier_str	oai:repositorio.unisucre.edu.co:001/1627
network_acronym_str	RUNISUCRE2
network_name_str	Repositorio Unisucre
repository_id_str
dc.title.spa.fl_str_mv	Efectos adversos relacionados al uso de AINEs en el manejo de osteoartritis felina y canina
dc.title.translated.eng.fl_str_mv	Adverse effects related to the use of NSAIDs in the management of feline and canine osteoarthritis
title	Efectos adversos relacionados al uso de AINEs en el manejo de osteoartritis felina y canina
spellingShingle	Efectos adversos relacionados al uso de AINEs en el manejo de osteoartritis felina y canina Secondary effect osteoarthritis drug therapy renal insufficiency pets cyclooxygenase inhibitors Efectos secundario osteoartritis tratamiento farmacológico insuficiencia renal mascotas inhibidores de la ciclooxigenasa
title_short	Efectos adversos relacionados al uso de AINEs en el manejo de osteoartritis felina y canina
title_full	Efectos adversos relacionados al uso de AINEs en el manejo de osteoartritis felina y canina
title_fullStr	Efectos adversos relacionados al uso de AINEs en el manejo de osteoartritis felina y canina
title_full_unstemmed	Efectos adversos relacionados al uso de AINEs en el manejo de osteoartritis felina y canina
title_sort	Efectos adversos relacionados al uso de AINEs en el manejo de osteoartritis felina y canina
dc.creator.fl_str_mv	González-Corrales, Daniela Monge-Quirós, Tatiana Alfaro-Mora, Ramses
dc.contributor.author.spa.fl_str_mv	González-Corrales, Daniela Monge-Quirós, Tatiana Alfaro-Mora, Ramses
dc.subject.eng.fl_str_mv	Secondary effect osteoarthritis drug therapy renal insufficiency pets cyclooxygenase inhibitors
topic	Secondary effect osteoarthritis drug therapy renal insufficiency pets cyclooxygenase inhibitors Efectos secundario osteoartritis tratamiento farmacológico insuficiencia renal mascotas inhibidores de la ciclooxigenasa
dc.subject.spa.fl_str_mv	Efectos secundario osteoartritis tratamiento farmacológico insuficiencia renal mascotas inhibidores de la ciclooxigenasa
publishDate	2020
dc.date.accessioned.none.fl_str_mv	2020-11-11 00:00:00 2022-07-01T17:16:17Z
dc.date.available.none.fl_str_mv	2020-11-11 00:00:00 2022-07-01T17:16:17Z
dc.date.issued.none.fl_str_mv	2020-11-11
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.eng.fl_str_mv	Journal article
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_dcae04bc
dc.type.content.spa.fl_str_mv	Text
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/ARTREV
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.uri.none.fl_str_mv	https://repositorio.unisucre.edu.co/handle/001/1627
dc.identifier.doi.none.fl_str_mv	10.24188/recia.v13.n1.2021.781
dc.identifier.eissn.none.fl_str_mv	2027-4297
dc.identifier.url.none.fl_str_mv	https://doi.org/10.24188/recia.v13.n1.2021.781
url	https://repositorio.unisucre.edu.co/handle/001/1627 https://doi.org/10.24188/recia.v13.n1.2021.781
identifier_str_mv	10.24188/recia.v13.n1.2021.781 2027-4297
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	Batlouni M. Antiinflamatorios No Esteoides: Efectos Cardiovasculares, Cerebrovasculares y Renales. Arq Bras Cardiol. 2010; 94(4):556-563. http://dx.doi.org/10.1590/S0066-782X2010000400019 Khan S, McLean M. Toxicology of Frequently Encountered Nonsteroidal Anti-Inflammatory Drugs in Dogs and Cats. Vet Clin Small Anim. 2012; 42:289–306. http://dx.doi.org/10.1016/j.cvsm.2012.01.003 Iff I. Non-steroidal anti-inflamatory drugs in dogs and cats-what´s new? Vet Irelan J. 2011; 1(9):506-510. https://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=86200534&lang=es&site=ehost-live Burian M, Geisslinger G. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol Ther. 2005; 107(2):139–154. http://dx.doi.org/10.1016/j.pharmthera.2005.02.004 López-Beceiro L, Fernández-Pérez S, Benguria-Astorqui L. Perforación gastrointestinal como consecuencia del uso de AINEs, Rev Complut Cienc Vet. 2007; 1(2):633-640. https://revistas.ucm.es/index.php/RCCV/article/view/RCCV0707230633A/22763 Alfaro R, Granados M, Camacho D. Polifarmacia en especies menores de clínicas veterinarias de la provincia de Heredia, en Costa Rica. Rev Colomb Cienc Quím. Farm. 2018; 47(1):5-13. https://doi.org/10.15446/rcciquifa.v47n1.70652 Müntener C, Bruckner L, Kupper J, Althaus F, Schäublin M. Vigilance for veterinary medicinal products: reports of adverse reactions in the year 2012. Schweiz Arch Tierheilkd. 2013; 155(11):613-620. http://dx.doi.org/10.1024/0036-7281/a000523 Müntener C., Bruckner L, Kupper J, Althaus F, Schäublin M. Vigilance for veterinary medicinal products: reports of adverse reactions in the year 2013. Schweiz Arch Tierheilkd. 2014; 156(11):519-525. http://dx.doi.org/10.1024/0036-7281/a000642 Radi Z. Pathophysiology of cyclooxygenase inhibition in animal models, Toxicol Pathol. 2009; 37:34-46. https://doi.org/10.1177/0192623308329474 Bergh M, Budsberg S. The coxib NSAIDs: potential clinical and pharmacologic importance in veterinary medicine. J Vet Intern Med. 2005; 19:633-643. https://doi.org/10.1892/0891-6640(2005)19[633:tcnpca]2.0.co;2 Stolfi C, De Simone V, Pallone F, Monteleone G. Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer. Int J Mol Sci. 2013; 14:17972-17985. http://dx.doi.org/10.3390/ijms140917972 Rao P, Kabir S, Mohamed T. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development. Pharmaceuticals. 2010; 3:1530-1549. http://dx.doi.org/10.3390/ph3051530 Schellack N, Schellack G, Fourie J. A review of nonsteroidal anti-inflammatory drugs. S Afr Pharm J. 2015; 82(3):8-18. http://www.sapj.co.za/index.php/SAPJ/article/download/1988/3481 Maddison J. Cats and NSAIDs- what are the issues?. Irish Veterinary Journal. 2007; 60(3):174-178. https://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=24946789&lang=es&site=ehost-live Schwab J, Schluesener H, Laufer S. COX-3: just another COX or the solitary elusive target of paracetamol? Lancet. 2003; 361(9362): 981-982. https://doi.org/10.1016/S0140-6736(03)12841-3 Chandrasekharan N, Dai H, Turepu K, Evanson N, Tomsik J, Elton T. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. PNAS. 2002; 99(21):13926-13931. http://dx.doi.org/10.1073/pnas.162468699 Sparkes A, Heiene R, Lascelles B, Malik R, Sampietro L, Robertson S. ISFM and AAFP consensus guidelines: long – term use of NSAIDs in cats. J Feline Med Surg. 2010; 12(7):521-538. https://www.wsava.org/wp-content/uploads/2020/01/Guidelines-for-the-Long-Term-Use-of-NSAIDS-in-Cats.pdf Jones R. Nonsteroidal anti-inflammatory drugs in the cat. Vet Anaesth Analg. 2007; 34:225–227. http://dx.doi.org/10.1111/j.1467-2995.2007.00372.x Tangmahakul N., Soontornvipart K., Nganvongpanit K. Comparison of the efficacy of firocoxib and carprofen in clinical use for canine coxofemoral osteoarthritis. Thai J Vet Med. 2015; 45(3):351-362. http://www.thaiscience.info/Journals/Article/TJVM/10978194.pdf Less P. Pharmacology of drugs used to treat osteoarthritis in veterinary practice. Inflammopharmacology. 2003; 11(4):385-399. https://link.springer.com/article/10.1163/156856003322699564 Innes J, Clayton J, Lascelles B. Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis. Vet Rec. 2010; 166:226-230. http://dx.doi.org/10.1136/vr.c97 Innes J, O´Neill T, Lascelles D. Use of non-steroidal anti-inflammatory drugs for the treatment of canine osteoarthritis. In Practice. 2010; 32:126-137. http://dx.doi.org/10.1136/inp.c1436 Lomas A, Grauer G. The Renal Effects of NSAIDs in Dogs. J Am Anim Hosp Assoc. 2015; 51(3):197-203. https://doi.org/10.5326/JAAHA-MS-6239 Sanderson R, Beata C, Flipo R, Genevois J, Macias C, Tacke S. Systematic review of the management of canine osteoarthritis. Vet Rec. 2009; 164(14):418-424. https://doi.org/10.1136/vr.164.14.418 Lees P., Pelligand L, Elliott J, Toutain P, Michels G, Stegemann M. Pharmacokinetics, pharmacodynamics, toxicology and therapeutics of mavacoxib in the dog: a review. J Vet Pharmacol Ther. 2014; 38(1):1-14. http://dx.doi.org/10.1111/jvp.12185 Robertson S. Osteoarthitis in cats: what we now know about recognition and treatment. Vet Med. 2008; 103(11):611-616. https://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=35372473&lang=es&site=ehost-live Ruiz J. Factores fisiológicos que modifican la acción de los fármacos en medicina veterinaria. Rev Col Cienc Pec. 2001; 14(1):36-48. https://revistas.udea.edu.co/index.php/rccp/article/view/323750/20780937 Lascelles B, Henderson AJ, Hackett IJ. Evaluation of the clinical efficacy of meloxicam in cats with painful locomotor disorders. J Small Anim Pract. 2001; 42(12):587-593. https://doi.org/10.1111/j.1748-5827.2001.tb06034.x Hunt J, Dean R, Davis G., Murrell J. An analysis of the relative frequencies of reported adverse events associated with NSAID administration in dogs and cats in the United Kingdom. Vet J. 2015; 206(2):183–190. https://doi.org/10.1016/j.tvjl.2015.07.025 Lascelles B, Hansen B, Roe S, DePuy V, Thomson A, Pierce C. Evaluation of client– specific outcome measures and activity monitoring to measure pain relief in cats with osteoarthritis. J Vet Intern Med. 2007; 21(3):410-416. https://doi.org/10.1111/j.1939-1676.2007.tb02983.x Szweda M, Szarek J, Kielbowicz Z, Szynaka B. Side-effects of non-steroidal anti-inflammatory drugs on the liver in dogs and hepatoprotective effect of plant remedies. Bull Vet Inst Pulawy. 2014; 58(3):459-466. https://doi.org/10.2478/bvip-2014-0070 Valadan M, Shojaee-Tabrizi A, Sarchahi AA, Derakhshandeh A, Mirzaeian S. Comparison of gastric adverse effects of aspirin and celecoxib before and after eradicating Helicobacter spp. infection in dogs. IJVR. 2014; 15(2):154-158. http://ijvr.shirazu.ac.ir/article_2363_0eaf6030011d0bd11615ed312df0ebca.pdf King J, Rudaz C, Borer L, Jung M, Seewald W., Lees P. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study. Res Vet Sci. 2010; 88(3):497-506. https://doi.org/10.1016/j.rvsc.2009.11.002 Webb C, Twedt D. Canine gastritis. Vet Clin North Am Small Anim Pract. 2003; 33(5):969-985. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124327/ Richardson J. Management of Acetaminophen and Ibuprofen toxicosis in dogs and cats. J Vet Emerg Critic Care. 2007; 10(4):285-291. https://doi.org/10.1111/j.1476-4431.2000.tb00013.x Davis M, Williamson K. Gastritis and gastric ulcers in work dogs. Front Vet Sci. 2016; 3:30. https://doi.org/10.3389/fvets.2016.00030 Fusellier M, Desfontis J, Madec S. Effect of tepoxalin on renal function in healthy dogs receiving an angiotensin-converting enzyme inhibitor J Vet Pharmacol Ther. 2005; 28(6):581-586. https://doi.org/10.1111/j.1365-2885.2005.00685.x Surdyk K, Sloan D, Brown S. Evaluation of the renal effects of ibuprofen and carprofen in euvolemic and volume-depleted dogs. Intern J Appl Res Vet Med. 2011; 9:129-136. http://www.jarvm.com/articles/Vol9Iss2/Vol9%20Iss1Brown.pdf Boelsterli U. Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. Toxicol Appl Pharmacol. 2003; 192(3):307-322. https://doi.org/10.1016/S0041-008X(03)00368-5 Reymond N, Speranza C, Gruet P, Seewald W, King J. Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial. J Vet Pharmacol Ther. 2012; 35(2):175-183. https://doi.org/10.1111/j.1365-2885.2011.01297.x Nakagawa K, Yamagami T, Takemura N. Hepatocellular toxicosis associated with the alternate administration of carprofen and meloxicam in a siberian husky. J Vet Med Sci. 2005; 67(10):1051-1053. https://doi.org/10.1292/jvms.67.1051 Siroka Z. The toxicity and adverse effects of selected drugs in animals – overview. Pol J Vet Sci. 2013; 16(1):181–191. http://journals.pan.pl/dlibra/publication/114082/edition/99140/content Sutalo S, Ruetten M, Hartnack S. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats. J Vet Intern Med. 2015; 29(3):840-846. https://doi.org/10.1111/jvim.12580 Parkinson S, Tolbert K, Messenger K, Odunayo A, Brand M, Davidson G, el al. Evaluation of the Effect of Orally Administered Acid Suppressants on Intragastric pH in Cats. J Vet Intern Med. 2015; 29(1):104–112. https://doi.org/10.1111/jvim.12493 Takeuchi H. The role of food for the formation and prevention of gastrointestinal lesions induced by aspirin in cats. Digestive Diseases and Sciences. 2013; 58(10):2840–2849. http://dx.doi.org/10.1007/s10620-013-2725-7 Sumano-López H, Ocampo-Camberos L. Farmacología Veterinaria 3 ed. McGraw-Hill Interamericana: México D.F; 2006. https://es.scribd.com/doc/55938774/Farmacologia-Veterinaria-Tercera-Edicion-Sumano-Ocampo Plumb D. Plumb´s Veterinary Drug Handbook. 7th ed, PharmaVet Inc: Wisconsin; 2011. https://books-library.online/files/download-pdf-ebooks.org-kupd-190.pdf Ettinger S, Feldman E. Veterinary Internal Medicine. Diseases of the dog and the cat. 8th ed, Saunders Elsevier; 2017. https://evolve.elsevier.com/cs/product/9780323312110?role=student
dc.relation.bitstream.none.fl_str_mv	https://revistas.unisucre.edu.co/index.php/recia/article/download/e781/915
dc.relation.citationedition.spa.fl_str_mv	Núm. 1 , Año 2021 : RECIA 13(1):ENERO-JUNIO 2021
dc.relation.citationendpage.none.fl_str_mv	e781
dc.relation.citationissue.spa.fl_str_mv	1
dc.relation.citationstartpage.none.fl_str_mv	e781
dc.relation.citationvolume.spa.fl_str_mv	13
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Colombiana de Ciencia Animal - RECIA
dc.rights.spa.fl_str_mv	Revista Colombiana de Ciencia Animal - RECIA - 2020
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	Revista Colombiana de Ciencia Animal - RECIA - 2020 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Universidad de Sucre
dc.source.spa.fl_str_mv	https://revistas.unisucre.edu.co/index.php/recia/article/view/e781
institution	Universidad de Sucre
bitstream.url.fl_str_mv	https://repositorio.unisucre.edu.co/bitstreams/0c197c2a-db04-4e6a-a226-fb1fb07392d0/download
bitstream.checksum.fl_str_mv	8a3912f0ea20c72d2864e2937720c416
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Institucional Universidad de Sucre
repository.mail.fl_str_mv	bdigital@metabiblioteca.com
_version_	1814111948056297472
spelling	González-Corrales, Danieladf10ee5f6dbeee8d5e52b90d5b6a2ea4300Monge-Quirós, Tatiana0d4c65637bc182689830e5fe1d4c2b9e300Alfaro-Mora, Ramses41bb2e3edaa4ddc0661846dcb3f6e2fe3002020-11-11 00:00:002022-07-01T17:16:17Z2020-11-11 00:00:002022-07-01T17:16:17Z2020-11-11https://repositorio.unisucre.edu.co/handle/001/162710.24188/recia.v13.n1.2021.7812027-4297https://doi.org/10.24188/recia.v13.n1.2021.781application/pdfspaUniversidad de SucreRevista Colombiana de Ciencia Animal - RECIA - 2020https://creativecommons.org/licenses/by-nc-sa/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2https://revistas.unisucre.edu.co/index.php/recia/article/view/e781Secondary effectosteoarthritisdrug therapyrenal insufficiencypetscyclooxygenase inhibitorsEfectos secundarioosteoartritistratamiento farmacológicoinsuficiencia renalmascotasinhibidores de la ciclooxigenasaEfectos adversos relacionados al uso de AINEs en el manejo de osteoartritis felina y caninaAdverse effects related to the use of NSAIDs in the management of feline and canine osteoarthritisArtículo de revistaJournal articleinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_dcae04bchttp://purl.org/coar/resource_type/c_2df8fbb1Texthttp://purl.org/redcol/resource_type/ARTREVhttp://purl.org/coar/version/c_970fb48d4fbd8a85Batlouni M. Antiinflamatorios No Esteoides: Efectos Cardiovasculares, Cerebrovasculares y Renales. Arq Bras Cardiol. 2010; 94(4):556-563. http://dx.doi.org/10.1590/S0066-782X2010000400019Khan S, McLean M. Toxicology of Frequently Encountered Nonsteroidal Anti-Inflammatory Drugs in Dogs and Cats. Vet Clin Small Anim. 2012; 42:289–306. http://dx.doi.org/10.1016/j.cvsm.2012.01.003Iff I. Non-steroidal anti-inflamatory drugs in dogs and cats-what´s new? Vet Irelan J. 2011; 1(9):506-510. https://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=86200534&lang=es&site=ehost-liveBurian M, Geisslinger G. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol Ther. 2005; 107(2):139–154. http://dx.doi.org/10.1016/j.pharmthera.2005.02.004López-Beceiro L, Fernández-Pérez S, Benguria-Astorqui L. Perforación gastrointestinal como consecuencia del uso de AINEs, Rev Complut Cienc Vet. 2007; 1(2):633-640. https://revistas.ucm.es/index.php/RCCV/article/view/RCCV0707230633A/22763Alfaro R, Granados M, Camacho D. Polifarmacia en especies menores de clínicas veterinarias de la provincia de Heredia, en Costa Rica. Rev Colomb Cienc Quím. Farm. 2018; 47(1):5-13. https://doi.org/10.15446/rcciquifa.v47n1.70652Müntener C, Bruckner L, Kupper J, Althaus F, Schäublin M. Vigilance for veterinary medicinal products: reports of adverse reactions in the year 2012. Schweiz Arch Tierheilkd. 2013; 155(11):613-620. http://dx.doi.org/10.1024/0036-7281/a000523Müntener C., Bruckner L, Kupper J, Althaus F, Schäublin M. Vigilance for veterinary medicinal products: reports of adverse reactions in the year 2013. Schweiz Arch Tierheilkd. 2014; 156(11):519-525. http://dx.doi.org/10.1024/0036-7281/a000642Radi Z. Pathophysiology of cyclooxygenase inhibition in animal models, Toxicol Pathol. 2009; 37:34-46. https://doi.org/10.1177/0192623308329474Bergh M, Budsberg S. The coxib NSAIDs: potential clinical and pharmacologic importance in veterinary medicine. J Vet Intern Med. 2005; 19:633-643. https://doi.org/10.1892/0891-6640(2005)19[633:tcnpca]2.0.co;2Stolfi C, De Simone V, Pallone F, Monteleone G. Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer. Int J Mol Sci. 2013; 14:17972-17985. http://dx.doi.org/10.3390/ijms140917972Rao P, Kabir S, Mohamed T. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development. Pharmaceuticals. 2010; 3:1530-1549. http://dx.doi.org/10.3390/ph3051530Schellack N, Schellack G, Fourie J. A review of nonsteroidal anti-inflammatory drugs. S Afr Pharm J. 2015; 82(3):8-18. http://www.sapj.co.za/index.php/SAPJ/article/download/1988/3481Maddison J. Cats and NSAIDs- what are the issues?. Irish Veterinary Journal. 2007; 60(3):174-178. https://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=24946789&lang=es&site=ehost-liveSchwab J, Schluesener H, Laufer S. COX-3: just another COX or the solitary elusive target of paracetamol? Lancet. 2003; 361(9362): 981-982. https://doi.org/10.1016/S0140-6736(03)12841-3Chandrasekharan N, Dai H, Turepu K, Evanson N, Tomsik J, Elton T. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. PNAS. 2002; 99(21):13926-13931. http://dx.doi.org/10.1073/pnas.162468699Sparkes A, Heiene R, Lascelles B, Malik R, Sampietro L, Robertson S. ISFM and AAFP consensus guidelines: long – term use of NSAIDs in cats. J Feline Med Surg. 2010; 12(7):521-538. https://www.wsava.org/wp-content/uploads/2020/01/Guidelines-for-the-Long-Term-Use-of-NSAIDS-in-Cats.pdfJones R. Nonsteroidal anti-inflammatory drugs in the cat. Vet Anaesth Analg. 2007; 34:225–227. http://dx.doi.org/10.1111/j.1467-2995.2007.00372.xTangmahakul N., Soontornvipart K., Nganvongpanit K. Comparison of the efficacy of firocoxib and carprofen in clinical use for canine coxofemoral osteoarthritis. Thai J Vet Med. 2015; 45(3):351-362. http://www.thaiscience.info/Journals/Article/TJVM/10978194.pdfLess P. Pharmacology of drugs used to treat osteoarthritis in veterinary practice. Inflammopharmacology. 2003; 11(4):385-399. https://link.springer.com/article/10.1163/156856003322699564Innes J, Clayton J, Lascelles B. Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis. Vet Rec. 2010; 166:226-230. http://dx.doi.org/10.1136/vr.c97Innes J, O´Neill T, Lascelles D. Use of non-steroidal anti-inflammatory drugs for the treatment of canine osteoarthritis. In Practice. 2010; 32:126-137. http://dx.doi.org/10.1136/inp.c1436Lomas A, Grauer G. The Renal Effects of NSAIDs in Dogs. J Am Anim Hosp Assoc. 2015; 51(3):197-203. https://doi.org/10.5326/JAAHA-MS-6239Sanderson R, Beata C, Flipo R, Genevois J, Macias C, Tacke S. Systematic review of the management of canine osteoarthritis. Vet Rec. 2009; 164(14):418-424. https://doi.org/10.1136/vr.164.14.418Lees P., Pelligand L, Elliott J, Toutain P, Michels G, Stegemann M. Pharmacokinetics, pharmacodynamics, toxicology and therapeutics of mavacoxib in the dog: a review. J Vet Pharmacol Ther. 2014; 38(1):1-14. http://dx.doi.org/10.1111/jvp.12185Robertson S. Osteoarthitis in cats: what we now know about recognition and treatment. Vet Med. 2008; 103(11):611-616. https://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=35372473&lang=es&site=ehost-liveRuiz J. Factores fisiológicos que modifican la acción de los fármacos en medicina veterinaria. Rev Col Cienc Pec. 2001; 14(1):36-48. https://revistas.udea.edu.co/index.php/rccp/article/view/323750/20780937Lascelles B, Henderson AJ, Hackett IJ. Evaluation of the clinical efficacy of meloxicam in cats with painful locomotor disorders. J Small Anim Pract. 2001; 42(12):587-593. https://doi.org/10.1111/j.1748-5827.2001.tb06034.xHunt J, Dean R, Davis G., Murrell J. An analysis of the relative frequencies of reported adverse events associated with NSAID administration in dogs and cats in the United Kingdom. Vet J. 2015; 206(2):183–190. https://doi.org/10.1016/j.tvjl.2015.07.025Lascelles B, Hansen B, Roe S, DePuy V, Thomson A, Pierce C. Evaluation of client– specific outcome measures and activity monitoring to measure pain relief in cats with osteoarthritis. J Vet Intern Med. 2007; 21(3):410-416. https://doi.org/10.1111/j.1939-1676.2007.tb02983.xSzweda M, Szarek J, Kielbowicz Z, Szynaka B. Side-effects of non-steroidal anti-inflammatory drugs on the liver in dogs and hepatoprotective effect of plant remedies. Bull Vet Inst Pulawy. 2014; 58(3):459-466. https://doi.org/10.2478/bvip-2014-0070Valadan M, Shojaee-Tabrizi A, Sarchahi AA, Derakhshandeh A, Mirzaeian S. Comparison of gastric adverse effects of aspirin and celecoxib before and after eradicating Helicobacter spp. infection in dogs. IJVR. 2014; 15(2):154-158. http://ijvr.shirazu.ac.ir/article_2363_0eaf6030011d0bd11615ed312df0ebca.pdfKing J, Rudaz C, Borer L, Jung M, Seewald W., Lees P. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study. Res Vet Sci. 2010; 88(3):497-506. https://doi.org/10.1016/j.rvsc.2009.11.002Webb C, Twedt D. Canine gastritis. Vet Clin North Am Small Anim Pract. 2003; 33(5):969-985. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124327/Richardson J. Management of Acetaminophen and Ibuprofen toxicosis in dogs and cats. J Vet Emerg Critic Care. 2007; 10(4):285-291. https://doi.org/10.1111/j.1476-4431.2000.tb00013.xDavis M, Williamson K. Gastritis and gastric ulcers in work dogs. Front Vet Sci. 2016; 3:30. https://doi.org/10.3389/fvets.2016.00030Fusellier M, Desfontis J, Madec S. Effect of tepoxalin on renal function in healthy dogs receiving an angiotensin-converting enzyme inhibitor J Vet Pharmacol Ther. 2005; 28(6):581-586. https://doi.org/10.1111/j.1365-2885.2005.00685.xSurdyk K, Sloan D, Brown S. Evaluation of the renal effects of ibuprofen and carprofen in euvolemic and volume-depleted dogs. Intern J Appl Res Vet Med. 2011; 9:129-136. http://www.jarvm.com/articles/Vol9Iss2/Vol9%20Iss1Brown.pdfBoelsterli U. Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. Toxicol Appl Pharmacol. 2003; 192(3):307-322. https://doi.org/10.1016/S0041-008X(03)00368-5Reymond N, Speranza C, Gruet P, Seewald W, King J. Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial. J Vet Pharmacol Ther. 2012; 35(2):175-183. https://doi.org/10.1111/j.1365-2885.2011.01297.xNakagawa K, Yamagami T, Takemura N. Hepatocellular toxicosis associated with the alternate administration of carprofen and meloxicam in a siberian husky. J Vet Med Sci. 2005; 67(10):1051-1053. https://doi.org/10.1292/jvms.67.1051Siroka Z. The toxicity and adverse effects of selected drugs in animals – overview. Pol J Vet Sci. 2013; 16(1):181–191. http://journals.pan.pl/dlibra/publication/114082/edition/99140/contentSutalo S, Ruetten M, Hartnack S. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats. J Vet Intern Med. 2015; 29(3):840-846. https://doi.org/10.1111/jvim.12580Parkinson S, Tolbert K, Messenger K, Odunayo A, Brand M, Davidson G, el al. Evaluation of the Effect of Orally Administered Acid Suppressants on Intragastric pH in Cats. J Vet Intern Med. 2015; 29(1):104–112. https://doi.org/10.1111/jvim.12493Takeuchi H. The role of food for the formation and prevention of gastrointestinal lesions induced by aspirin in cats. Digestive Diseases and Sciences. 2013; 58(10):2840–2849. http://dx.doi.org/10.1007/s10620-013-2725-7Sumano-López H, Ocampo-Camberos L. Farmacología Veterinaria 3 ed. McGraw-Hill Interamericana: México D.F; 2006. https://es.scribd.com/doc/55938774/Farmacologia-Veterinaria-Tercera-Edicion-Sumano-OcampoPlumb D. Plumb´s Veterinary Drug Handbook. 7th ed, PharmaVet Inc: Wisconsin; 2011. https://books-library.online/files/download-pdf-ebooks.org-kupd-190.pdfEttinger S, Feldman E. Veterinary Internal Medicine. Diseases of the dog and the cat. 8th ed, Saunders Elsevier; 2017. https://evolve.elsevier.com/cs/product/9780323312110?role=studenthttps://revistas.unisucre.edu.co/index.php/recia/article/download/e781/915Núm. 1 , Año 2021 : RECIA 13(1):ENERO-JUNIO 2021e7811e78113Revista Colombiana de Ciencia Animal - RECIAPublicationOREORE.xmltext/xml2671https://repositorio.unisucre.edu.co/bitstreams/0c197c2a-db04-4e6a-a226-fb1fb07392d0/download8a3912f0ea20c72d2864e2937720c416MD51001/1627oai:repositorio.unisucre.edu.co:001/16272024-04-17 16:31:07.217https://creativecommons.org/licenses/by-nc-sa/4.0/Revista Colombiana de Ciencia Animal - RECIA - 2020metadata.onlyhttps://repositorio.unisucre.edu.coRepositorio Institucional Universidad de Sucrebdigital@metabiblioteca.com

Efectos adversos relacionados al uso de AINEs en el manejo de osteoartritis felina y canina

Publicaciones similares